RadNet touts ‘disproportionately higher’ growth in advanced imaging

RadNet Inc. is touting “disproportionately higher” growth in advanced imaging when compared to other routine exams, with the company revising its financial projections to reflect recent success. 

The Los Angeles-based, publicly traded imaging center operator officially announced its second quarter earnings results on Sunday. RadNet estimated that aggregate advance imaging procedural volumes leapt 21.2% in Q2 compared to the same period in 2025, or 9.6% when only counting centers the company operated both quarters. 

This disproportionally higher growth in MR, CT and PET/CT relative to routine imaging contributed to a 238 basis-point shift in RadNet’s advanced imaging procedural volume mix. The company estimated about 29.9% of its scans were advanced imaging in the three months ending June 30, up from 27.5% (or 2.38 percentage points) in Q2 of 2025. 

Coupled with its digital health segment, which includes AI and other technology tool, RadNet achieved a “record” quarter, with total revenue up 25% year over year, to nearly $623 million. 

“The imaging center and digital health reportable operating segments continue to demonstrate strong growth and achieve record quarterly results,” President and CEO Howard Berger, MD, said in a statement Aug. 9. “Growth was driven by strong increases in aggregate and same center procedural volumes, the contribution from recent acquisitions, a continuing shift in procedural volumes towards advanced imaging and incremental digital health sales and licenses of enterprise imaging and AI solutions,” he added later. 

This “favorable business mix shift” toward advanced modalities contributed to a 16.1% adjusted earnings margin for the imaging center segment in Q2. Berger said this represents a 17 basis-point improvement as compared to the same three months in 2025. 

Compared to last year, MRI volumes increased by about 21%, CT by 20.9% and PET/CT volumes were up 31%. Routine imaging—including nuclear medicine, ultrasound, mammography and X-ray—increased by about 7.9%. However, RadNet executed several recent acquisitions that may inflate these numbers. When only comparing on a same-center basis and excluding the impact of newly added centers, MRI was up 10.2%, CT 8.6%, PET/CT 8.8%, and routine scans about 1.7%. 

Berger highlighted growth in its joint venture partnerships with hospital systems as one reason for the success. As of June 30, about 36% (or 157 of its 442 imaging centers) were held through health system partnerships. During Q2, RadNet announced a multisite venture in Boise, Idaho, with Trinity Health’s Saint Alphonsus Health System. This would initially include operations of five multimodality outpatient centers. As part of the partnership, RadNet’s contracted imaging group, Gem State Radiology, and the local hospitals will be adopting several AI solutions made by its DeepHealth subsidiary. 

Given the successes seen in Q2, RadNet is revising its financial projections for 2026. The company now expects to log upward of $2.42 billion in total net revenue from its imaging center segment, up from original projections of up to $2.375 billion. It’s also forecasting up to $358 million in adjusted earnings, up from original estimates of $348 million. 

You can read much more about the company’s earnings results in the announcement. RadNet plans to host a quarterly earnings call to discuss the figures at 10:30 a.m. Eastern Time on Monday, Aug. 10, with simultaneous and archived webcasts available here.